Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

(2017) Tsukasa Shibue et al.   Nature Reviews Clinical Oncology

Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells

(2017) Peter Ping Lin et al.   Scientific Reports

Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer

(2016) Kyung-A Hyun et al.   Oncotarget

The Epithelial-Mesenchymal Transition and Cancer Stem Cells: Functional and Mechanistic Links

(2015) Xiangqiang Liu et al.   CURRENT PHARMACEUTICAL DESIGN

T15

(2015) E. Kaigorodova et al.   EJC SUPPLEMENTS

Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression

(2015) Xin Ye et al.   TRENDS IN CELL BIOLOGY

Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells

(2015) Feng Ge et al.   Oncotarget

EMT, CTCs and CSCs in tumor relapse and drug-resistance

(2015) Abhisek Mitra et al.   Oncotarget

The relationship between weight change and risk of hip fracture: meta-analysis of prospective studies

(2015) Qing-Bo Lv et al.   Scientific Reports

Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts

(2014) Suling Liu et al.   Stem Cell Reports

Overview: Cellular plasticity, cancer stem cells and metastasis

(2013) Wael M. ElShamy et al.   CANCER LETTERS

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

(2013) Poornima Bhat-Nakshatri et al.   Scientific Reports

Promotion of epithelial-mesenchymal transition and tumor growth by 17β-estradiol in an ER+/HER2+ cell line derived from human breast epithelial stem cells

(2012) Kai-Hung Wang et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer

(2012) Cheng-Wei Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

(2012) A. Giordano et al.   MOLECULAR CANCER THERAPEUTICS

TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

(2011) M. K. Asiedu et al.   CANCER RESEARCH

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

(2011) Michal Mego et al.   INTERNATIONAL JOURNAL OF CANCER

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

The social aspects of EMT-MET plasticity

(2011) E W Thompson et al.   NATURE MEDICINE

Nuclear signalling by tumour-associated antigen EpCAM

(2009) Dorothea Maetzel et al.   NATURE CELL BIOLOGY

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

(2008) Anne-Pierre Morel et al.   PLoS One